Skip to content

2019

Dose De-Escalation to Adalimumab 40 Mg Every Three Weeks in Patients With Inflammatory Bowel disease-A Multicenter, Retrospective, Observational Study

Articles,2019
Lieven Pouillon , Anne Lamoureux , Guillaume Pineton de Chambrun , Lucine Vuitton , Benjamin Pariente , Camille Zallot , Gaspard Dufour , Mathurin Fumery , Cédric Baumann , Aurélien Amiot , Stéphane Nancey…
Lire la suite

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Articles,2019
Pellet G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, Roblin X, Allimant C, Nachury M, Nancey S, Filippi J, Altwegg R, Brixi H, Fotsing G, de Rosamel L, Shili S, Laharie D (Clin Gastroenterol Hepatol.…
Lire la suite

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Articles,2019
Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G,…
Lire la suite

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.

Articles,2019
Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G,…
Lire la suite

Adalimumab for Patients With Crohn’s Disease Complicated by Intra-Abdominal Abscess: A Multicentre, Prospective, Observational Cohort Study

Articles,2019
G Pineton de Chambrun , B Pariente , P Seksik , R Altwegg , L Vuitton , C Stefasnescu , S Nancey , A Aubourg , M Serrero , L Peyrin-Biroulet , J Filippi…
Lire la suite

La version de votre navigateur est obsolète et votre appareil est exposé à des risques de sécurité.

Pour profiter d'une expérience optimale sur ce site il est fortement recommandé de mettre à jour votre navigateur ou d'en installer un autre :